Skip to main content
Cellular & Molecular Biology Letters logoLink to Cellular & Molecular Biology Letters
. 2007 Feb 23;12(3):370–377. doi: 10.2478/s11658-007-0009-y

High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone

Yoshifumi S Hirokawa 1,, Akimitsu Takagi 1, Katsunori Uchida 1, Yuji Kozuka 1, Misao Yoneda 1, Masatoshi Watanabe 2, Taizo Shiraishi 1
PMCID: PMC6275712  PMID: 17318295

Abstract

In this paper, we describe the isolation and characterization of two PC3 subclones. One subclone, mr, showed an epithelial phenotype, the other, M1, showed a sarcomatous morphology. Transplanted into nude mice, mr developed tumors at a dramatically faster rate than M1. Comparing the two subclones, differentially expressed genes were identified, including E-cadherin, IL-8 and STAG1/PMEPA1. These genes were expressed at higher levels in mr than in M1.

Keywords: STAG1/PMEPA1, IL-8, E-cadherin, Prostate cancer cell line

Full Text

The Full Text of this article is available as a PDF (607.6 KB).

Abbreviations used

DHT

5α-dihydrotestosterone

IL-8

interleukin-8

PSA

prostate specific antigen

STAG1

solid tumor associated gene 1

STR

short tandem repeat

References

  • 1.Sobel R.E., Sadar M.D. Cell lines used in prostate cancer research: a compendium of old and new lines—part 1. J. Urol. 2005;173:342–359. doi: 10.1097/01.ju.0000141580.30910.57. [DOI] [PubMed] [Google Scholar]
  • 2.Rokhlin O.W., Cohen M.B. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate. 1995;26:205–212. doi: 10.1002/pros.2990260406. [DOI] [PubMed] [Google Scholar]
  • 3.Kim S.J., Uehara H., Karashima T., Mccarty M., Shih N., Fidler I.J. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia. 2001;3:33–42. doi: 10.1038/sj.neo.7900124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Inoue K., Slaton J.W., Kim S.J., Perrotte P., Eve B.Y., Bar-Eli M., Radinsky R., Dinney C.P. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res. 2000;60:2290–2299. [PubMed] [Google Scholar]
  • 5.Cheng L., Nagabhushan M., Pretlow T.P., Amini S.B., Pretlow T.G. Expression of E-cadherin in primary and metastatic prostate cancer. Am. J. Pathol. 1996;148:1375–1380. [PMC free article] [PubMed] [Google Scholar]
  • 6.Umbas R., Isaacs W.B., Bringuier P.P., Schaafsma H.E., Karthaus H.F., Oosterhof G.O., Debruyne F.M., Schalken J.A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res. 1994;54:3929–3933. [PubMed] [Google Scholar]
  • 7.Xu L.L., Shi Y., Petrovics G., Sun C., Makarem M., Zhang W., Sesterhenn I.A., McLeod D.G., Sun L., Moul J.W., Srivastava S. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res. 2003;63:4299–42304. [PubMed] [Google Scholar]
  • 8.Micka K.A., Sprecher C.J., Lins A.M., Theisen Comey C., Koons B.W., Crouse C., Endean D., Pirelli K., Lee S.B., Duda N., Ma M., Schumm J.W. Validation of multiplex polymorphic STR amplification sets developed for personal identification applications. J. Forensic. Sci. 1996;41:582–90. [PubMed] [Google Scholar]
  • 9.Moore B.B., Arenberg D.A., Stoy K., Morgan T., Addison C.L., Morris S.B., Glass M., Wilke C., Xue Y.Y., Sitterding S., Kunkel S.L., Burdick M.D., Strieter R.M. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol. 1999;154:1503–1512. doi: 10.1016/S0002-9440(10)65404-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Murphy C., McGurk M., Pettigrew J., Santinelli A., Mazzucchelli R., Johnston P.G., Montironi R., Waugh D.J. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin. Cancer Res. 2005;11:4117–4127. doi: 10.1158/1078-0432.CCR-04-1518. [DOI] [PubMed] [Google Scholar]
  • 11.Brunschwig E.B., Wilson K., Mack D., Dawson D., Lawrence E., Willson J.K., Lu S., Nosrati A., Rerko R.M., Swinler S., Beard L., Lutterbaugh J.D., Willis J., Platzer P., Markowitz S. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res. 2003;63:1568–1575. [PubMed] [Google Scholar]
  • 12.Giannini G., Ambrosini M.I., Di Marcotullio L., Cerignoli F., Zani M., MacKay A.R., Screpanti I., Frati L., Gulino A. EGF-and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer. Mol. Carcinog. 2003;38:188–200. doi: 10.1002/mc.10162. [DOI] [PubMed] [Google Scholar]
  • 13.Lu S., Dong Z. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells. Prostate. 2006;66:996–1004. doi: 10.1002/pros.20424. [DOI] [PubMed] [Google Scholar]
  • 14.Tran N.L., Nagle R.B., Cress A.E., Heimark R.L. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am. J. Pathol. 1999;155:787–798. doi: 10.1016/S0002-9440(10)65177-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cellular & Molecular Biology Letters are provided here courtesy of BMC

RESOURCES